Creative BioMart to Present at
                        BIO-Europe Spring Creative BioMart to Present at AACR Annual Meeting|Apr. 5-10, 2024|Booth #2953

Active Recombinant Human ACVR1B, Fc Chimera

Cat.No. : ACVR1B-189H
Product Overview : Recombinant Human ACVR1B (Accession # AAA60556) was produced in Mouse myeloma cell line, NS0-derived.
  • Specification
  • Gene Information
  • Related Products
Source : Mammalian cells
Species : Human
Tag : Fc Chimera
Predicted N Terminal : Leu32
Form : Lyophilized from a 0.2 µm filtered solution in PBS.
Bio-activity : Measured by its binding ability in a functional ELISA.Immobilized rhActivin RIB/Fc Chimera at 2 µg/mL (100 µL/well) can bind rhCripto with a linear range of 0.8 - 100 ng/mL.
Molecular Mass : Recombinant Human ACVR1B, Fc Chimera has a calculated MW of 37.5 kDa (monomer). In SDS-PAGE migrates as 45-50 kDa, reducing conditions.
Purity : >90%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Storage : Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC).
Gene Name : ACVR1B activin A receptor, type IB [ Homo sapiens ]
Official Symbol : ACVR1B
Synonyms : ACVR1B; activin A receptor, type IB; ACVRLK4; activin receptor type-1B; ActRIB; ALK4; SKR2; activin receptor-like kinase 4; activin A receptor, type II-like kinase 4; serine/threonine-protein kinase receptor R2; ACTRIB;
Gene ID : 91
mRNA Refseq : NM_004302
Protein Refseq : NP_004293
MIM : 601300
UniProt ID : P36896
Chromosome Location : 12q13

For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.

Inquiry

0

Inquiry Basket

cartIcon
logo

FOLLOW US

Terms and Conditions        Privacy Policy

Copyright © 2024 Creative BioMart. All Rights Reserved.

Contact Us

  • /

Stay Updated on the Latest Bioscience Trends